Investor Material

Anavex Life Sciences presentation at Cowen Conference

Anavex Life Sciences 2017 Financial Results Conference Call and Webcast

Anavex® corporate presentation at The Jefferies 2017 Global Healthcare Conference on June 9, 2017

Anavex® corporate presentation at Ladenburg Thalmann 2016 Healthcare Conference

Anavex® corporate presentation at 18th Annual BIO CEO & Investor Conference on February 9, 2016

Anavex® Life Sciences Reports PK and PD Data from Phase 2a Trial of ANAVEX®2-73 in Mild-to-Moderate Alzheimer’s Disease Patients

Anavex® rings the Nasdaq Stock Market Closing Bell on October 30, 2015